Actual Medicinal Product (AMP) -
Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)
Name Details
|
Current Name
Incruse Ellipta 55micrograms/dose dry powder inhaler
|
Start Date
09-10-2014
|
End Date
|
Summary
- Licensed Route
- Inhalation
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| BNF |
|
Previous BNF
03010200
|
Start Date
14-01-2015
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 27567911000001101 |
09-10-2014 |
|
Actual Medicinal Product Pack (AMPP) Information